Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Lee JW;Lee JW;Lee JW; Lim NK; Lim NK; Park HY; Park HY
  • المصدر:
    BMC endocrine disorders [BMC Endocr Disord] 2018 May 30; Vol. 18 (1), pp. 33. Date of Electronic Publication: 2018 May 30.
  • نوع النشر :
    Journal Article
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6823 (Electronic) Linking ISSN: 14726823 NLM ISO Abbreviation: BMC Endocr Disord Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central, [2001-
    • الموضوع:
    • نبذة مختصرة :
      Background: Screening for risk of type 2 diabetes mellitus (T2DM) is an important public health issue. Previous studies report that fasting plasma glucose (FPG) and triglyceride (TG)-related indices, such as lipid accumulation product (LAP) and the product of fasting glucose and triglyceride (TyG index), are associated with incident T2DM. We aimed to evaluate whether FPG or TG-related indices can improve the predictive ability of a diabetes risk model for middle-aged Koreans.
      Methods: 7708 Koreans aged 40-69 years without diabetes at baseline were eligible from the Korean Genome and Epidemiology Study. The overall cumulative incidence of T2DM was 21.1% (766 cases) in men and 19.6% (797 cases) in women. Therefore, the overall cumulative incidence of T2DM was 20.3% (1563 cases). Multiple logistic regression analysis was conducted to compare the odds ratios (ORs) for incident T2DM for each index. The area under the receiver operating characteristic curve (AROC), continuous net reclassification improvement (cNRI), and integrated discrimination improvement (IDI) were calculated when each measure was added to the basic risk model for diabetes.
      Results: All the TG-related indices and FPG were more strongly associated with incident T2DM than WC in our study population. The adjusted ORs for the highest quartiles of WC, TG, FPG, LAP, and TyG index compared to the lowest, were 1.64 (95% CI, 1.13-2.38), 2.03 (1.59-2.61), 3.85 (2.99-4.97), 2.47 (1.82-3.34), and 2.79 (2.16-3.60) in men, and 1.17 (0.83-1.65), 2.42 (1.90-3.08), 2.15 (1.71-2.71), 2.44 (1.82-3.26), and 2.85 (2.22-3.66) in women, respectively. The addition of TG-related parameters or FPG, but not WC, to the basic risk model for T2DM (including age, body mass index, family history of diabetes, hypertension, current smoking, current drinking, and regular exercise) significantly increased cNRI, IDI, and AROC in both sexes.
      Conclusions: Adding either TyG index or FPG into the basic risk model for T2DM increases its prediction and reclassification ability. Compared to FPG, TyG index was a more robust T2DM predictor in the stratified sex and fasting glucose level. Therefore, TyG index should be considered as a screening tool for identification of people at high risk for T2DM in practice.
    • References:
      Diabetes Care. 2003 Mar;26(3):725-31. (PMID: 12610029)
      Clin Chem. 1972 Jun;18(6):499-502. (PMID: 4337382)
      Diabetologia. 2009 Mar;52(3):443-50. (PMID: 19057891)
      PLoS One. 2016 Sep 28;11(9):e0163465. (PMID: 27682598)
      Circ J. 2012;76(8):1904-10. (PMID: 22640983)
      Diabetes Care. 2008 Jan;31(1):96-8. (PMID: 17921357)
      PLoS One. 2014 Feb 28;9(2):e90430. (PMID: 24587359)
      Prev Med. 2008 Oct;47(4):389-93. (PMID: 18619998)
      PLoS One. 2016 May 23;11(5):e0156155. (PMID: 27214034)
      Stat Med. 2011 Jan 15;30(1):11-21. (PMID: 21204120)
      Prev Med. 2016 May;86:99-105. (PMID: 26854766)
      Circulation. 2002 Dec 17;106(25):3143-421. (PMID: 12485966)
      Acta Diabetol. 2015 Aug;52(4):781-8. (PMID: 25572334)
      Diabetes Metab J. 2011 Aug;35(4):303-8. (PMID: 21977448)
      Am J Epidemiol. 2010 May 1;171(9):980-8. (PMID: 20375194)
      Int J Epidemiol. 2017 Apr 1;46(2):e20. (PMID: 27085081)
      Diabet Med. 2011 Jan;28(1):23-30. (PMID: 21166842)
      Clin Chem. 1993 Apr;39(4):561-77. (PMID: 8472349)
      Diabetes Res Clin Pract. 2007 Jan;75(1):72-80. (PMID: 16735075)
      Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12. (PMID: 17569110)
      Diabetes Care. 2010 Jan;33 Suppl 1:S62-9. (PMID: 20042775)
      BMJ. 2011 Nov 28;343:d7163. (PMID: 22123912)
      J Hum Hypertens. 2004 Oct;18(10):717-23. (PMID: 15116144)
      Epidemiology (Sunnyvale). 2016 Apr;6(2):null. (PMID: 27274911)
      Lipids Health Dis. 2017 Sep 13;16(1):175. (PMID: 28903774)
      BMC Public Health. 2012 Dec 15;12:1081. (PMID: 23241342)
      Biometrics. 1988 Sep;44(3):837-45. (PMID: 3203132)
      Eur J Clin Nutr. 2013 Jan;67(1):25-30. (PMID: 23149979)
      Medicine (Baltimore). 2016 May;95(19):e3646. (PMID: 27175686)
      Diabetes Res Clin Pract. 2017 Aug 9;:null. (PMID: 28951335)
      Arch Intern Med. 2007 May 28;167(10):1068-74. (PMID: 17533210)
      J Intern Med. 2015 Apr;277(4):498-500. (PMID: 25156816)
      Int J Obes Relat Metab Disord. 1997 Nov;21(11):995-1001. (PMID: 9368822)
      Lancet Diabetes Endocrinol. 2014 Jun;2(6):474-80. (PMID: 24731674)
      Diabetes Care. 2012 Aug;35(8):1723-30. (PMID: 22688547)
      Rev Diabet Stud. 2011 Winter;8(4):490-8. (PMID: 22580730)
      Diabetes Care. 2006 Jan;29(1):151-3. (PMID: 16373916)
      J Diabetes. 2018 Jan 11;:null. (PMID: 29322661)
      Diabetes Res Clin Pract. 2011 Sep;93(3):e98-e100. (PMID: 21665314)
      Diabetes Care. 2011 May;34 Suppl 2:S210-4. (PMID: 21525457)
    • Grant Information:
      4800-4845-302 (2017-NI63001-00) Korea National Institute of Health
    • Contributed Indexing:
      Keywords: Risk model; TyG index; Type 2 diabetes mellitus
    • الرقم المعرف:
      0 (Biomarkers)
      0 (Blood Glucose)
      0 (Triglycerides)
    • الموضوع:
      Date Created: 20180531 Date Completed: 20180928 Latest Revision: 20181114
    • الموضوع:
      20240829
    • الرقم المعرف:
      PMC5975474
    • الرقم المعرف:
      10.1186/s12902-018-0259-x
    • الرقم المعرف:
      29843706